Amylyx Pharmaceuticals is a clinical-stage company focused on post-bariatric hypoglycemia, Wolfram syndrome, and amyotrophic lateral sclerosis (ALS).
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. We are a clinical-stage company focused on post-bariatric hypoglycemia, Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our Regional Scientific Director will serve as a field-based scientific, medical expert to the medical/academic community, responsible for establishing and maintaining relationships with Key Opinion Leaders and Health Care Providers/Professionals.
Amylyx Pharmaceuticals is a clinical-stage company focused on post-bariatric hypoglycemia, Wolfram syndrome, and amyotrophic lateral sclerosis (ALS).
Axsome Therapeutics